Longitudinal study tracks humoral immunity response against SARS-CoV-2 in convalescent individuals

Close Monitoring for Heart Risk Needed if Breast, Prostate Cancer Treatment Includes Hormones

American Heart Association/American Stroke Association Stroke Council Leadership provides guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine

Resting Heart Rate as a Cardiovascular Risk Factor in Hypertensive Patients: An Update

Study details incidence of thrombosis in children and adolescents hospitalised with COVID-19 or MIS-C

Prior use of therapeutic anticoagulation does not protect against COVID-19-related clinical outcomes in hospitalised patients: Study

ASH President: Hematologic Complications of COVID-19 Vaccines Are Rare

Managing dyslipidemia in patients with type 2 diabetes

Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19

EMA finds possible link between COVID-19 Vaccine Janssen and very rare cases of unusual blood clots with low blood platelets

Study suggests one dose of COVID-19 vaccine may be sufficient for nursing home residents with prior infection to obtain high levels of antibody

HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk

SARS-CoV-2 B.1.1.7 variant associated with increased viral load, but not increased disease severity: Study

Beta-Blockers May Alter Cardiovascular Disease Risk in Patients With HIV, Hypertension

Study details post-discharge thromboembolic outcomes and mortality of hospitalised COVID-19 patients

EMA finds possible link between AstraZeneca's COVID-19 vaccine and very rare cases of unusual blood clots with low blood platelets